Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease

Area of Science:

• Biotechnology
• Molecular Biology
• Infectious Disease Diagnostics

Background:

• Infectious diseases pose significant public health and economic threats globally.
• Traditional nucleic acid detection methods face limitations in speed and precision.
• CRISPR-Cas systems, originally for genome engineering, offer programmable precision.

Purpose of the Study:

• To review the application of CRISPR-Cas systems as biosensors for nucleic acid detection.
• To explore the capabilities of CRISPR-Cas in identifying genetic mutations and microbial pathogens.
• To discuss the advantages and challenges of developing CRISPR-Cas for point-of-care (POC) diagnostics.

Main Methods:

• Review of current literature on CRISPR-Cas enzyme utility in biosensing.
• Analysis of CRISPR-Cas mechanisms for recognition, signal amplification, and detection.
• Evaluation of CRISPR-Cas technology for diagnostic applications.

Main Results:

• CRISPR-Cas systems function as effective biosensors for accurate nucleic acid detection.
• These systems enable rapid, multiplexed biomarker identification for tumors and pathogens.
• CRISPR-Cas technology demonstrates potential for improved rational redesign in biosensing.

Conclusions:

• CRISPR-Cas biosensors represent a significant advancement in diagnostic technology.
• The review provides insights into the current status and future potential of CRISPR-Cas for rapid POC diagnostics.
• Overcoming current hurdles is crucial for widespread adoption of CRISPR-Cas diagnostic tools.